Novo Nordisk's pipeline, especially the oral GLP-1 and Alzheimer’s trial, offers significant long-term upside. Click here to ...

Animal studies support that theory. GLP-1 drugs reduce inflammation in the brain and interfere with reward pathways linked to ...

An updated edition of the June 4, 2025 article. The world is in the midst of a historic demographic shift with populations ...

Dr Rowan French insists lasting weight loss can only be achieved through a balanced approach to psychology, exercise and ...

For decades, the story of Alzheimer's research has been dominated by a battle between A-beta and tau amyloids, both of which ...

Historically, managing type 2 diabetes in advanced chronic kidney disease (CKD) has been challenging due to a lack of therapies and increased risks for adverse events.

Monthly weight-loss shots on the horizon! Learn about new drugs like MariTide and why Black participation in clinical trials ...

Weight loss drugs like Ozempic, while effective, are linked to significant side effects, leading many users to discontinue ...